Ignite Creation Date:
2025-12-24 @ 1:37 PM
Ignite Modification Date:
2025-12-29 @ 11:36 AM
Study NCT ID:
NCT04828395
Status:
UNKNOWN
Last Update Posted:
2021-05-11
First Post:
2021-03-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fluzoparib Combined With Camrelizumab for Maintenance Treatment of Locally Advanced Non-small Cell Lung Cancer
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-21
First Submit QC Date:
None
Study First Post Date:
2021-04-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-07
Last Update Post Date:
2021-05-11
Last Update Post Date Type:
ACTUAL